News

New research published in the American Journal of Health-System Pharmacy suggests a possible link between the GLP-1 drug ...
Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...
The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...
Since being approved for weight-loss in November 2023, Mounjaro, which contains a GLP-1 drug similar to semaglutide, has already been linked to 209 adverse reactions, one of which was fatal.
Researchers estimated that nearly 25,000 ED visits were related to semaglutide adverse events. They were surprised to learn that 16% involved hypoglycemia. An estimated 24,499 people visited the ...
Visceral fat, or adipose tissue, within the abdomen is more strongly associated with health problems than subcutaneous fat under the skin ... as well as reaction time and processing speed. The overall ...
It has received reports of adverse reactions from people who have used compounded semaglutide and has noted that pharmacies may be using a different form of semaglutide that does not work in the ...